AARC临床实践指南:急症成人患者的氧气管理
该指南由美国呼吸治疗协会(AARC)制定,采用RAND/UCLA适宜性方法改良版,基于系统评价回答氧合目标、监测、经鼻高流量氧疗(HFO)早期启动、HFO与常规氧疗比较及加温湿化等问题。最终形成7条推荐:大多数住院患者目标SpO₂ 94-98%,COPD患者88-92%,重症患者同样94-98%;促进早期启动HFO;可考虑HFO以避免升级至无创通气;拔管后立即考虑HFO以避免再插管;免疫功能受损患者HFO或常规氧疗均可;流量>4 L/min时考虑加温湿化。
要点
- 大多数住院成人目标SpO₂ 94-98%;COPD患者目标SpO₂ 88-92%。
- 重症患者目标SpO₂同样为94-98%。
- 推荐早期启动经鼻高流量氧疗(HFO)。
- 可考虑HFO以避免升级至无创通气;拔管后立即考虑HFO以避免再插管。
- 免疫功能受损患者HFO或常规氧疗均可;流量>4 L/min时考虑加温湿化。
适用人群与场景
- 住院成人患者,包括重症患者
- COPD患者
- 拔管后患者
- 免疫功能受损患者
诊断标准与关键阈值
- 大多数住院患者目标SpO₂ 94-98%
- COPD患者目标SpO₂ 88-92%
- 重症患者目标SpO₂ 94-98%
处置流程与药物剂量
- 推荐早期启动经鼻高流量氧疗(HFO)
- 可考虑HFO以避免升级至无创通气
- 拔管后立即考虑HFO以避免再插管
- 免疫功能受损患者可使用HFO或常规氧疗
- 补充氧流量>4 L/min时考虑加温湿化
研究设计与关键结果
- 采用RAND/UCLA适宜性方法改良版制定7条推荐,指导住院成人补充氧疗。
证据类型、等级与局限
- 证据类型:临床实践指南,基于系统评价
- 局限:原文未报告局限性
对床旁实践的改变
- 按指南推荐设定SpO₂目标:大多数住院患者94-98%,COPD患者88-92%,重症患者94-98%。
- 对适合患者早期启动HFO,可考虑用于避免升级至无创通气及拔管后避免再插管。
- 免疫功能受损患者HFO或常规氧疗均可;流量>4 L/min时考虑加温湿化。
指南或共识出处
- AARC Clinical Practice Guideline: Management of Adult Patients With Oxygen in the Acute Care Setting(美国呼吸治疗协会,年份原文未提及)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Providing supplemental oxygen to hospitalized adults is a frequent practice and can be administered via a variety of devices. Oxygen therapy has evolved over the years, and clinicians should follow evidence-based practices to provide maximum benefit and avoid harm. This systematic review and subsequent clinical practice guidelines were developed to answer questions about oxygenation targets, monitoring, early initiation of high-flow oxygen (HFO), benefits of HFO compared to conventional oxygen therapy, and humidification of supplemental oxygen. Using a modification of the RAND/UCLA Appropriateness Method, 7 recommendations were developed to guide the delivery of supplemental oxygen to hospitalized adults: (1) aim for [Formula: see text] range of 94-98% for most hospitalized patients (88-92% for those with COPD), (2) the same [Formula: see text] range of 94-98% for critically ill patients, (3) promote early initiation of HFO, (4) consider HFO to avoid escalation to noninvasive ventilation, (5) consider HFO immediately postextubation to avoid re-intubation, (6) either HFO or conventional oxygen therapy may be used with patients who are immunocompromised, and (7) consider humidification for supplemental oxygen when flows > 4 L/min are used.
参考来源
- Piraino, Madden, Roberts, et al. AARC Clinical Practice Guideline: Management of Adult Patients With Oxygen in the Acute Care Setting. Respir Care. 2021. PMID: 34728574. doi:10.4187/respcare.09294
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。